Common Sources of Peptide Impurities

Peptide impurities can appear at several points during synthesis, purification, storage and handling. They are not always caused by one major mistake. Small changes in peptide manufacture often lead to the formation of unwanted variants that persist in the final material.

Knowing the origin of these impurities can be useful for research purposes to interpret quality data for a peptide. A peptide might have the correct name and the molecular mass you expect, but that doesn’t mean every molecule in the sample has the structure you want.

Type and amount of impurity may differ depending on the peptide sequence, method of synthesis, purification process and storage conditions. Common examples include incomplete sequences, oxidised forms, degradation products, residual chemicals and aggregated material.

Impurities formed during peptide synthesis

Many synthetic peptides are produced using solid-phase peptide synthesis (SPPS). This process adds one amino acid at a time to build up the sequence you want. Each coupling and deprotection step needs to work properly. If a reaction does not go to completion, an unwanted peptide variant can be produced.

One common example is a deletion sequence. This happens when one amino acid is unsuccessfully added during synthesis. The resulting peptide is therefore shorter than the intended sequence. If this situation happens more than once, several related deletion products can be present in the same batch.

The opposite can also happen. Insertion impurity: An additional amino acid may be incorporated. This can occur when excess amino acid reagents or incomplete washing contribute to an unintended addition during chain assembly.

Incomplete removal of protecting groups can create another group of impurities. During synthesis we use protecting groups to stop certain parts of an amino acid from reacting at the wrong time. If not removed well enough, changed forms of the peptide could remain.

These problems become more difficult as peptide sequences become longer or more complicated. Longer chains can also become harder to keep soluble during synthesis, which may encourage aggregation and make purification more challenging.

Oxidation and other chemical changes

Some amino acids are more sensitive to chemical changes than others. Methionine, cysteine, tryptophan and some other residues can undergo oxidation under suitable conditions.

For example, methionine can be converted into methionine sulphoxide. Cysteine can oxidise and take part in disulphide formation. These changes can result in a peptide that is very similar to the target molecule but no longer chemically identical.

The main step of synthesis does not need to be oxidation. It can occur during cleavage, purification, sample preparation or storage. Exposure to light, oxygen, reactive chemicals and trace metal ions can all contribute to oxidative changes in susceptible peptides.

This phenomenon is one reason peptide quality needs to be considered across the whole handling process rather than only at the point of synthesis.

Deamidation and degradation products

Peptides can also undergo degradation after they have been produced. Deamidation is one example. Chemical alteration of residues like asparagine or glutamine occurs, leading to the formation of another form of the peptide.

Hydrolysis, racemisation, as well as isomerisation and many other transformations can also take place in peptide molecules. The chance of these reactions occurring depends upon the sequence of peptides and the environmental conditions surrounding the peptide, including temperature and pH, among others.

Some peptide-specific side reactions can be more difficult to identify because the resulting impurity may be very similar to the intended peptide. Aspartimide formation, for example, is a recognised side reaction in peptide chemistry and can occur under certain synthesis conditions.

This is why simply looking for a completely different molecular mass is not enough to identify every possible impurity.

Aggregates and higher-molecular-weight material

Not all impurities are smaller than the target peptide. Peptide molecules can also associate with one another and form dimers, oligomers or larger aggregates.

Aggregation can happen during synthesis when growing peptide chains interact with each other. It can also occur later because of temperature changes, pH, shaking, interfaces with equipment or other handling stresses.

Aggregated material is particularly relevant because it may not behave like individual peptide molecules. It can also make purification harder, especially when the aggregate has similar properties to the desired peptide.

Storage conditions therefore matter as much as manufacturing conditions. A peptide that leaves purification in good condition can still develop degradation or aggregation if it is exposed to unsuitable conditions later.

Residual reagents, solvents and process materials

Not every unwanted substance in a peptide sample is another peptide.

Synthesis and purification use various reagents, solvents and processing materials. If they are not properly removed, traces can remain in the final material. Examples include solvents used in purification and reagents associated with peptide synthesis.

There can also be unwanted counterions or chemical residues associated with the purification process. For this reason, peptide quality assessment can involve more than measuring peptide purity alone.

Why the source of an impurity matters

Knowing that a sample contains an impurity is useful, but knowing what the impurity is and where it came from provides much more information.

A deletion sequence points towards an issue during chain assembly. Oxidation may be indicative of a chemical change during synthesis, purification or storage. Aggregation may be a sign of physical instability or poor handling. Residual solvent is indicative of a different stage of the manufacturing process.

Also, different types of impurities may require different analytical approaches. Reversed-phase chromatography is a commonly utilised technique to separate peptide-like compounds and mass spectrometry could assist in the determination of the molecular mass and identification of related species. Some closely related impurities can be difficult to distinguish using only one analytical technique.

Reading peptide quality information

When reviewing peptide testing information, it helps to look beyond a single purity percentage. A reported purity figure can tell you how much of the detected material corresponds to the main component under a particular analytical method, but it does not explain every possible impurity.

Useful information can include the analytical method used, the reported purity, the expected molecular mass, the observed mass and any available chromatographic or mass-spectrometry data.

The important point is that peptide impurities can have several sources. Some are introduced during synthesis, some develop through chemical or physical changes, and others come from processing or storage. Understanding these sources makes it easier to read testing information and ask sensible questions about the quality of a research peptide.